Results 41 to 50 of about 6,347 (225)
Cutaneous ageing manifests itself as a progressive reduction in maximum function and reserve capacity of skin tissue. It is not a unique and uniform biological event. Skin comprises three layers: epidermis, dermis and subcutaneous tissue.
Brincat, Mark P. +2 more
core +1 more source
Plant-derived 5 α-reductase inhibitors, such as β-sitosterol and phytosterol glycosides, have been used to treat androgenic alopecia, but their oral absolute bioavailability is poor.
Kousalya Prabahar +3 more
doaj +1 more source
Androgenic alopecia in postmenopausal ovarian hyperthecosis
A 70-year-old woman presented with a 5-year history of progressive hirsutism and baldness. She had her menarche at age of 13 years and had had normal periods from then until the menopause (at age o...
K, Ashawesh, M M, Aghilla, H S, Randeva
openaire +2 more sources
Effect of recombinant collagen 17 spray on male androgenic alopecia
[Objective] To observe the effect of recombinant collagen 17 spray on male androgenic alopecia. [Methods] From September 2024 to December 2024, 30 men with androgenic alopecia were treated with recombinant collagen 17 spray twice daily at the dermatology
SHANG Zhiwei +3 more
doaj +1 more source
Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights
Summary of the microbiome‐lipid‐microinflammation axis in androgenetic alopecia (AGA). Altered sebaceous gland activity, shifts in microbial abundance on the scalp and hair follicle, and follicular microinflammation interact bidirectionally, each reinforcing the others.
Aditya K. Gupta +3 more
wiley +1 more source
Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women [PDF]
BACKGROUND: There is no consensus on the standard treatment options for female pattern androgenetic alopecia (AGA). Efficacy of finasteride in women is controversial. The purpose of this study was to evaluate the clinical efficacy and safety of 5 mg/day
André, MC +3 more
core +1 more source
Background: Androgenic alopecia (AGA) is characterized by hair follicle miniaturization and chronic inflammation mediated by dihydrotestosterone (DHT).
Denawati Denawati +2 more
doaj +1 more source
Laser-assisted Hair Regrowth: Fractional Laser Modalities for the Treatment of Androgenic Alopecia
Background:. A large proportion of the population is at sometime affected by androgenic alopecia. Current therapies consisting of minoxidil or finasteride are often the first choices for treatment.
Robert J. Dabek, MD +2 more
doaj +1 more source
Hair loss due to a new coronavirus infection: treatment approaches
Stress has always been one of the triggers of hair loss. The global pandemic of COVID-19 infection has become such a factor for many people. Considering that the pathogenesis of hair loss in this infection has not been sufficiently studied yet, many ...
L. R. Sakania +2 more
doaj +1 more source
Optimization of photobiomodulation therapy for spinal cord injury: A review
Photobiomodulation (PBM) therapy in the red and near‐infrared range can significantly modulate the secondary injury response and promote the reparative and regenerative potential of neural tissue after spinal cord injury (SCI). At present, due to the nature of delivery methods, the most effective dose and irradiance at the injury site to optimize ...
Isabella K. M. Drew +3 more
wiley +1 more source

